05:53 PM EST, 12/12/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said it appointed Dietmar Berger as its chief medical officer, effective Jan. 2, replacing Merdad Parsey.

Berger brings over 25 years of experience in "developing and delivering innovative medicines across a broad range of therapeutic areas," Gilead said late Thursday. He will also join Gilead's senior leadership team.

Most recently, Berger was the CMO at Sanofi ( SNY ) .